title: Blocking T helper 1/T helper 17 pathways has no effect on patch testing.
authors.affiliation: Department of Allergology and Clinical Immunology, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, 69495 Pierre Bénite Cedex, France. audrey.nosbaum@chu-lyon.fr
authors.forename: Audrey
authors.initials: A
authors.lastname: Nosbaum
authors.forename: Aurore
authors.initials: A
authors.lastname: Rozieres
authors.forename: Brigitte
authors.initials: B
authors.lastname: Balme
authors.forename: Catherine
authors.initials: C
authors.lastname: Goujon
authors.forename: Jean-François
authors.initials: JF
authors.lastname: Nicolas
authors.forename: Frédéric
authors.initials: F
authors.lastname: Bérard
mesh_terms: D000911:Antibodies, Monoclonal / Q000494:pharmacology* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D003429:Cross Reactions; D017449:Dermatitis, Allergic Contact / Q000175:diagnosis / Q000209:etiology / Q000276:immunology*; D005260:Female; D006634:Histamine H1 Antagonists / Q000009:adverse effects* / Q000276:immunology; D006801:Humans; D006919:Hydroxyzine / Q000009:adverse effects* / Q000276:immunology; D008875:Middle Aged; D010328:Patch Tests; D011565:Psoriasis / Q000188:drug therapy; D006377:T-Lymphocytes, Helper-Inducer; D018417:Th1 Cells / Q000187:drug effects*; D058504:Th17 Cells / Q000187:drug effects*; D000069549:Ustekinumab
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D006634:Histamine H1 Antagonists; D006919:Hydroxyzine; D000069549:Ustekinumab